About Us

Tim Rudolphi

Tim Rudolphi – Chief Commercial Officer

Tim Rudolphi leads Emalex’s commercial preparations and all business development activities.

Mr. Rudolphi has more than 30 years of experience in the biopharmaceutical and MedTech industries, leading or participating in the launch of 16 products. His areas of expertise include: sales, global and U.S. marketing, market access, commercial operations, strategic planning, and business development.

Previously, he served as CEO of metaMe Health where he led the development and approval for one of the industry’s first prescription digital therapeutic products. Prior to this, Mr. Rudolphi was chief business officer at Aprecia Pharmaceuticals, the leader in 3-D printing of pharmaceutical drug products. Early in his career, he was one of the first 30 employees at Takeda Pharmaceuticals U.S., helping to build out the business with increasing roles and responsibilities.

Mr. Rudolphi earned his M.B.A. from Marquette University and his Bachelor of Science from the University of Illinois.